wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35740919-1840BD91-650B-442C-A3E5-73DF7663B811
Q35740919-1840BD91-650B-442C-A3E5-73DF7663B811
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35740919-1840BD91-650B-442C-A3E5-73DF7663B811
In silico Screening of Chemical Libraries to Develop Inhibitors That Hamper the Interaction of PCSK9 with the LDL Receptor.
P2860
Q35740919-1840BD91-650B-442C-A3E5-73DF7663B811
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35740919-1840BD91-650B-442C-A3E5-73DF7663B811
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
34b92728b9b218c35e654072217a9fd165c9593c
P2860
Efficacy and safety of longer-term administration of evolocumab (AMG 145) in patients with hypercholesterolemia: 52-week results from the Open-Label Study of Long-Term Evaluation Against LDL-C (OSLER) randomized trial.